Charles Schwab Investment Management Inc Adaptive Biotechnologies Corp Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,042,450 shares of ADPT stock, worth $18.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,042,450
Previous 922,742
12.97%
Holding current value
$18.6 Million
Previous $6.86 Million
77.16%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ADPT
# of Institutions
267Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$535 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$208 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$201 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$112 Million1.68% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.3MShares$76.7 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.55B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...